Company news

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) news

Cyclerion Therapeutics, Inc. news releases on 6ix. Latest, Oct 30, 2019: Cyclerion Therapeutics Announces Praliciguat Topline Phase 2 Results in Diabetic…

View Cyclerion Therapeutics, Inc. →

Press releases — page 2

Cyclerion Therapeutics Announces Praliciguat Topline Phase 2 Results in Diabetic Nephropathy

October 29, 2019

← Newer